Sherryll Layton, Rogers US
Sherryll Layton, Rogers, AR US
Patent application number | Description | Published |
---|---|---|
20110111015 | COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA - Vaccines comprising TRAP polypeptides and | 05-12-2011 |
20110159026 | COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO FLAGELLATED BACTERIUM - Vaccines comprising fliC and CD 154 polypeptides and | 06-30-2011 |
20120282291 | VACCINE VECTORS AND METHODS OF ENHANCING IMMUNE RESPONSES - Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a pharmaceutically acceptable carrier, suitably a carrier for oral or nasal administration. Also provided are methods of enhancing immune responses, in particular antibody immune response and suitably an IgA response, by administering the vaccine vectors or compositions disclosed herein to a subject. | 11-08-2012 |
20130084304 | VACCINE AND METHODS TO REDUCE CAMPYLOBACTER INFECTION - Vaccine vectors and methods for enhancing resistance to | 04-04-2013 |
20140093534 | COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES - Provided herein are | 04-03-2014 |
20150190496 | VACCINE AND METHODS TO REDUCE CAMPYLOBACTER INFECTION - Vaccine vectors and methods for enhancing resistance to | 07-09-2015 |
20150190500 | VACCINE VECTORS AND METHODS OF ENHANCING IMMUNE RESPONSES - Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a pharmaceutically acceptable carrier, suitably a carrier for oral or nasal administration. Also provided are methods of enhancing immune responses, in particular antibody immune response and suitably an IgA response, by administering the vaccine vectors or compositions disclosed herein to a subject. | 07-09-2015 |
20150216954 | COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA - Vaccines comprising TRAP polypeptides and | 08-06-2015 |